Related Experiment Videos
Differentiated thyroid carcinoma: risk group assignment and management controversies
P Fuchshuber1, T R Loree, M D DeLacure
1Department of Head and Neck, Roswell Park Cancer Institute, Buffalo, New York, USA.
Oncology (Williston Park, N.Y.)
|February 25, 1998
Summary
This review offers a clinical decision-making framework for differentiated thyroid cancer treatment in adults. It covers natural history, diagnosis, and controversies, including radioiodine therapy and TSH suppression.
Area of Science:
- Oncology
- Endocrinology
Background:
- Differentiated thyroid cancer (DTC) management requires a structured approach.
- Understanding DTC's natural history and pathogenesis is crucial for effective treatment.
Purpose of the Study:
- To establish a framework for clinical decision-making in adult DTC treatment.
- To comprehensively review diagnostic tools and therapeutic controversies.
Main Methods:
- Literature review focusing on differentiated thyroid cancer.
- Analysis of clinical discussions and treatment recommendations.
- Exploration of pathogenesis, diagnostic tools, and management controversies.
Main Results:
- The review synthesizes information on DTC natural history and pathogenesis.
- It assesses the roles of radioiodine therapy and TSH suppression.
- Locoregional disease treatment strategies are evaluated.
Conclusions:
- A comprehensive framework for DTC clinical decision-making is presented.
- The review provides guidance on managing differentiated thyroid cancer in adults.
- Key treatment issues, including radioiodine and TSH suppression, are addressed.